参考文献/References:
[1] Lewis WD,Lilly S,Jones KL.Lymphoma:Diagnosis and treatment[J].American Family Physician,2020,101(1):34-41.
[2] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.
[3] Cordier JF,Chailleux E,Lauque D,et al.Primary pulmonary lymphomas:A clinical-study of 70 cases in nonimmunocompromised patients[J].Chest,1993,103(1):201-208.
[4] William J,Variakojis D,Yeldandi A,et al.Lymphoproliferative neoplasms of the lung:A review[J].Archives of Pathology & Laboratory Medicine,2013,137(3):382-391.
[5] 蔡珩玉,周志星,周 迪,等.原发性和继发性肺淋巴瘤临床病理特征及预后因素分析[J].中国实验诊断学,2019,23(9):1567-1569.
[6] 张茁旭.肺继发性淋巴瘤的CT诊断与鉴别诊断[J].医学理论与实践,2010,23(6):717-718.
[7] 唐光才.肺淋巴瘤的影像学表现[J].内科急危重症杂志,2015,21(2):92-95.
[8] 单 华,顾雅佳,李文涛,等.肺继发性淋巴瘤的CT多样性[J].中国医学计算机成像杂志,2007,13(2):85-87.
[9] 孙 洁,郭佑民,付和睦,等.肺继发性淋巴瘤的CT诊断[J].实用放射学杂志,2002,18(8):670-672,674.
[10] Cunha BA,Hamid N,Krol V,et al.Fever of unknown origin due to preleukemia/myelodysplastic syndrome:The diagnostic importance of monocytosis with elevated serum ferritin levels[J].Heart & Lung,2006,35(4):277-282.
[11] 杨 笋,张明智.弥漫大B细胞淋巴瘤中血清铁蛋白的临床意义[J].河南医学研究,2018,27(13):2328-2331.
[12] Bjorkman PJ,Burmeister WP.Structures of 2 classes of mhc molecules elucidated-crucial differences and similarities[J].Current Opinion in Structural Biology,1994,4(6):852-856.
[13] Miyashita K,Tomita N,Taguri M,et al.Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy[J].Leukemia Research,2015,39(11):1187-1191.
[14] Kim HD,Cho H,Jeong H,et al.A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue international prognostic index and serum beta 2-microglobulin levels[J].British Journal of Haematology,2021,193:307-315.
[15] 宋为娟,杨瑞霞,张 燕.4种血清标志物在恶性淋巴瘤中的临床意义[J].检验医学与临床,2015,12(21):3155-3457.
[16] Habicht JM,Lori A,Stulz P,et al.Primary non-hodgkins-lymphoma of the lung-will videothoracoscopic biopsy change decision-making with regard to resection of this disease[J].Thoracic and Cardiovascular Surgeon,1994,42(2):112-115.
[17] Labarca G,Sierra-Ruiz M,Kheir F,et al.Diagnostic accuracy of endobronchial ultrasound transbronchial needle aspiration in lymphoma a systematic review and meta-analysis[J].Annals of the American Thoracic Society,2019,16(11):1432-1439.
[18] Borie R,Wislez M,Antoine M,et al.Pulmonary mucosa-associated lymphoid tissue lymphoma revisited[J].The European Respiratory Journal,2016,47(4):1244-1260.
[19] Koh MS,Tee A,Wong P,et al.Advances in lung cancer diagnosis and staging:Endobronchial ultrasound[J].Internal Medicine Journal,2008,38(2):85-89.
[20] Steinfort DP,Vincent J,Heinze S,et al.Comparative effectiveness of radial probe endobronchial ultrasound versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions:A randomized pragmatic trial[J].Respiratory Medicine,2011,105(11):1704-1711.
[21] Darwiche K,Özkan F,Wolters C,et al.Endobronchial ultrasound(EBUS)-Update 2017[J].Ultraschall in Der Medizin(Stuttgart,Germany:1980),2018,39(1):14-38.
[22] Zhan P,Zhu QQ,Miu YY,et al.Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer:A systematic review and meta-analysis[J].Translational Lung Cancer Research,2017,6(1):23-34.
[23] Görgüü FF,Öksüzler FY,Arslan SA,et al.Computed tomography-guided transthoracic biopsy:Factors influencing diagnostic and complication rates[J].The Journal of International Medical Research,2017,45(2):808-815.